Africa has the greatest disease burden in the world at about 25%. Despite this, less than 3% of clinical trials are conducted on the continent. This is a significant missed opportunity.
I saw some of the challenges researchers face when speaking with colleagues across the African continent. After attending the Women of Color in Pharma Global Summit in Nairobi, and visiting clinical trial sites to speak with site investigators, I developed a clearer vision of what pharmaceutical companies such as Sanofi can do to change this paucity of clinical trials.
So how can we transform Africa into a clinical trials powerhouse?
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Monique Adams
Monique Adams is the executive director, global head of diversity and inclusion in clinical trials, or DICT, at Sanofi where she drives the pharmaceutical company’s vision, strategy, and implementation of a holistic framework for DICT. Monique has a Ph.D. in Pharmacology from the University of Washington and received her M.S. in Physiology from Southern Illinois University.
